�ݺ�ߣ

An NDA (New Drug Application) is required for approval of a new drug that has never been approved for marketing in the United States. An ANDA (Abbreviated New Drug Application) is submitted for approval of a generic drug that is equivalent to an innovator drug already approved under an NDA. The ANDA relies on the safety and efficacy data of the reference listed drug and needs to demonstrate only bioequivalence to the reference listed drug.Read less